PRISM study of a Compound NCGC01219867
Cancelled Solicitation Posted
- Solicitation number
- 75N98026Q00990
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Acquisitions and Logistics Operations, seeks quotations for a PRISM study of compound NCGC01219867, with quotations due August 24, 2026 at 8:00 AM EST. This is an unrestricted, competitive acquisition conducted under FAR 12.603 as a streamlined solicitation for commercial services.
The requirement is for a Broad Institute pooled cancer cell line drug sensitivity screening. The contractor must test the compound against approximately 900 barcoded cancer cell lines in a standardized five-day assay using Luminex-format screening at 8-point dose with 3-fold dilution. The compound must be submitted as 1000x stock concentration in 100% DMSO. The period of performance runs from September 4 to October 3, 2026.
Deliverables include data detailing viability of all 900 cell lines, assay quality metrics, univariate and multivariate feature set correlation analysis, and all raw data from NCATS test agents, provided through the PRISM Portal. The Government will provide the analog to be screened. All data produced belongs to NCATS, and the contractor must maintain confidentiality.
Award will be made on a Firm-Fixed-Price basis to the responsible offeror offering best value, evaluated on price, technical capability, past performance, and delivery schedule. The NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences, with a small business size standard of 1000 employees. Quotations must include unit and total price, shipping and handling costs, delivery timeframe, delivery terms, F.O.B. point, product or service description, UEI, TIN, and business size certification. Offerors must be registered in SAM. Responses should be submitted electronically to Jaddua.Johnston@nih.gov. The contracting specialist is Jaddua Johnston, 240-569-0006.
Notice text
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00990. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026
(iv) The associated NAICS code is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and the small business size standard is 1000 employees.
This requirement is unrestricted.
Files
| File | Type | Posted |
|---|---|---|
| Sol_75N98026Q00990.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity